The effects of nigrostriatal 6-hydroxydopamine lesions on dopamine D2 receptor mRNA and opioid systems.
Mansour
A
A
MHRI, U Mich, Ann Arbor 48109.
Meador-Woodruff
J H
JH
Camp
D M
DM
Robinson
T E
TE
Bunzow
J
J
Van Tol
H
H
Civelli
O
O
Akil
H
H
Watson
S J
SJ
D000818:Animals; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism*; D004745:Enkephalins / Q000378:metabolism*; D006892:Hydroxydopamines / Q000494:pharmacology; D016627:Oxidopamine; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D011954:Receptors, Dopamine / Q000145:classification / Q000187:drug effects / Q000378:metabolism*; D013378:Substantia Nigra / Q000187:drug effects / Q000378:metabolism*; D014018:Tissue Distribution
D004745:Enkephalins; D006892:Hydroxydopamines; D012333:RNA, Messenger; D011954:Receptors, Dopamine; D016627:Oxidopamine